Health Minister J.P. Nadda today underscored India’s growing global leadership in medicines and vaccines. Speaking through a video message at the 60th Annual Summit of the Organisation of Pharmaceutical Producers of India (OPPI) in New Delhi, he emphasized the need for India to progress from being the pharmacy of the world to becoming the laboratory of the world. He also praised OPPI for its six decades of dedicated contribution to India’s pharmaceutical sector.
Showcasing a Decade of Progress
As reported by newsonair.gov.in, Mr Nadda highlighted India’s remarkable achievements over the past ten years. He noted that India now supplies medicines to more than 200 countries, accounts for a major share of the US and UK generic drug market, and produces 60% of the world’s vaccines. These milestones, he said, reflect India’s expanding capabilities and credibility in global healthcare.
Advancing Accessible and Affordable Healthcare
Furthermore, he pointed to transformative national initiatives. Ayushman Bharat has provided health protection to over 600 million people, significantly improving access to care. Meanwhile, Jan Aushadhi Kendras have reduced the cost of essential medicines, making treatment more affordable for millions of families.
OPPI’s Role in India’s Healthcare Transformation
During the summit, Dr V. K. Paul, Member, NITI Aayog, reiterated the critical role of OPPI and its member companies. He emphasized how innovation, partnerships, and scientific excellence are driving India’s healthcare transformation and shaping its future as a global leader in pharmaceutical innovation.
This year’s OPPI summit, therefore, not only celebrated the organisation’s legacy but also set a forward-looking vision for India’s evolving healthcare ecosystem.